Home » Topics » BioWorld Science

BioWorld Science
RSS

SIGLEC-6 targeting inhibits human mast cell degranulation and anaphylaxis

March 2, 2022

Bayer, Deutsches Krebsforschungszentrum patent aryl hydrocarbon receptor antagonists

March 2, 2022

Complement factor B inhibitors discovered at Shanghai Meiyue Biotech Development

March 2, 2022

Spexis, University of Zurich describe new antimicrobial peptidomimetics

March 2, 2022

Antengene Discover, Shanghai Antengene present new serine/threonine-protein kinase ATR inhibitors

March 2, 2022

New HDAC6 inhibitors identified at Italfarmaco

March 2, 2022

SpFN_1B-06-PL vaccine induces durable immune response against pathogens

March 1, 2022

PBI-0451 shows promising results for the treatment of COVID-19

March 1, 2022

Tonix enters research agreement with Inserm to study oxytocin in Prader-Willi syndrome mouse model

March 1, 2022

ANGPTL4 is elevated in peanut allergy

March 1, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...